• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • Making News

    ETF Daily News: How to Profit from the Rise of Macau


    3/7/14: ETF Daily News discusses the performance of gaming market Macau and mentions BJK. “Macau’s rise to prominence has been swift.”
    View article » 



    Benzinga: Interesting Similarities Among 2013's Top-Performing ETFs


    6/18/13: Todd Shriber evaluates the year’s notable ETFs and mentions BBH. He remarks that “biotech ETFs big and small have been stellar performers this year."
    View article » 



    Zacks Equity Research: Semiconductor ETFs for 2013?


    2/07/13: Zacks Equity Research reports that the semiconductor industry is "set to rebound in 2013 with the recovery projected to pick up speed in the latter part of the year" and advises investors to consider SMH as a vehicle for accessing the space.
    View article » 



  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
     

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Index Total Return Ticker

      MVPPHTR
    • Index Provider

      Market Vectors Index Solutions
    • Total Net Assets

      $321.9M
    • Shares Outstanding

      5,438,138
    • Number of Holdings

      26
    • Commencement Date

      12/20/2011
  •  
    as of 04/23/14

  • Key Points

    Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume
    Industry Leaders
    Index methodology favors the largest companies in the industry
    Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation
     
  • Trading Information

    • Fund Ticker

      PPH
    • Index Total Return Ticker

      MVPPHTR
    • NAV

      PPHNV
    • Intraday NAV (IIV)4

      PPHIV
    • Shares Outstanding

      5,438,138
    • Estimated Cash

      PPHEU
    • Total Cash

      PPHTC
    • CUSIP

      57060U217
    • ISIN

      US57060U2179
    Source: Bloomberg
  • Fees & Expenses2

    • Management Fee

      0.35%
    • Other Expenses

      0.08%
    • Gross Expense Ratio

      0.43%
    • Fee Waivers and
      Expense Reimbursement

      (0.08)%
    • Net Expense Ratio

      0.35%
    2 Expenses for PPH are capped contractually at 0.35% until at least 2/01/15. Cap excludes certain expenses, such as interest.
  • Prices as of 04/23/2014

    NAV/
    Last Price
    Volume
    30-Day Avg./
    Last Trading Day
    Daily Change
    NAV/
    Last Price
    YTD Change
    NAV/
    Last Price
    Premium/
    Discount
    Prem/Discount
    Distribution Charts
    NAV &
    Prem/Discount
    History
    NAV
    Chart
    PPH $59.19
    $59.21
    79,523
    76,777
    $-0.09 / -0.2%
    $-0.05 / -0.1%
    + 11.4%
    + 11.5%

    $0.02
    0.03%
  • View All Indices » View All ETFs » Performance History: Average Annual Total Returns* (%)

    1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR LIFE
    12/20/11
    PPH (NAV) -1.91 10.22 10.22 32.58 -- -- -- 26.75
    PPH (Share Price) -1.93 10.27 10.27 32.43 -- -- -- 27.26
    MVPPHTR (Index) -1.91 9.78 9.78 32.46 -- -- -- 26.61
    Performance Differential (NAV - Index) 0.00 0.44 0.44 0.12 -- -- -- 0.14
    1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR LIFE
    12/20/11
    PPH (NAV) -1.91 10.22 10.22 32.58 -- -- -- 26.75
    PPH (Share Price) -1.93 10.27 10.27 32.43 -- -- -- 27.26
    MVPPHTR (Index) -1.91 9.78 9.78 32.46 -- -- -- 26.61
    Performance Differential (NAV - Index) 0.00 0.44 0.44 0.12 -- -- -- 0.14
  • View All Holdings » Top 10 Holdings (%) as of 03/31/14

    Total Holdings: 26
    Holding Name
    Ticker
    Shares Market Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    302,182
    29,683,338 9.43
    Novartis Ag
    NVS US
    324,869
    28,378,281 9.02
    Pfizer Inc
    PFE US
    720,273
    23,135,169 7.35
    Merck & Co Inc
    MRK US
    289,470
    16,565,658 5.26
    Sanofi
    SNY US
    310,591
    16,237,697 5.16
    Novo Nordisk A/S
    NVO US
    342,784
    15,942,599 5.07
    Abbvie Inc
    ABBV US
    305,479
    15,701,621 4.99
    Glaxosmithkline Plc
    GSK US
    286,921
    15,532,083 4.94
    Teva Pharmaceutical Industries Ltd
    TEVA US
    287,973
    15,216,493 4.84
    Eli Lilly & Co
    LLY US
    239,822
    14,115,923 4.49
    Top 10 Total (%) 60.55
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.
  • Country Weightings (%)
    as of 03/31/14

    • Country

      % of Net Assets
    • U.S.

      59.1
    • UNITED KINGDOM

      9.3
    • SWITZERLAND

      9.0
    • FRANCE

      5.2
    • DENMARK

      5.1
    • ISRAEL

      4.8
    • CANADA

      4.1
    • IRELAND

      3.2
    • Other

      0.1
    • Total

      99.9
  • Sector Weightings (%)
    as of 03/31/14

    • Sector

      % of Net Assets
    • Health Care

      99.9
    • Other

      0.1
    • Total

      100.0